Yn dangos 406 i 420 o 2052 canlyniadau
Commonly asked record-keeping questions, answered
Katherine Timms, Head of Policy and Standards at the HCPC, answers the most common questions we receive from registrants about record keeping
Education annual data set: 2018-19 academic year
Snapshot of outcomes related to the HCPC’s education function for the 2018-19 academic year
HCPC gender, ethnicity and disability pay gaps report 2024
Annual reports on the gender and ethnicity pay gaps, with this year marking the first publication of the disability pay gap.
HCPC response to consultation on patient group directions for ODPs
Health and Care Professions Council response to NHS England’s consultation on the proposal for the supply and administration of medicines using patient group directions for operating department practitioners across the United Kingdom
Protected function - hearing aid dispensers
We regulate hearing aid dispensers on the basis of their professional title and also their protected function.
HCPC response to DHSC healthcare regulation consultation
As we move forward with the wider programme of regulatory reform, we welcome this consultation to consider how the powers to introduce and remove professions from regulation might be used in the future.
Before we begin
The first page you’ll see is the ‘Before we begin’ page
Assessing SET1 - Threshold level of qualification
This policy statement sets out our broad approach to assessing the threshold level of qualification for entry to the Register.
Launch of consultation for the standards of conduct, performance and ethics
Today we have launched a consultation which outlines proposed changes to the Standards of conduct, performance and ethics.
Professional bodies for occupational therapists
Professional bodies typically promote the profession, represent their members and provide curriculum frameworks, training and CPD.
HCPC Corporate Plan 2025-26
The HCPC Corporate Plan 2025-26 sets out how we will continue to make progress on each of our six strategic priorities over the year.
A review of our education outcomes for the academic year
We have looked back on our approval and monitoring outcomes from the last academic year
Reclassification of Gabapentin and Pregabalin
From midnight on 1st April 2019, gabapentin and pregabalin will be reclassified as Schedule 3 controlled drugs, under the Misuse of Drugs Regulations (2001), and Class C of the Misuse of Drugs Act (1971)